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Skeletal muscle function is important to the human body for daily activities.  
Mechanical signals are critical to the maintenance of that function.  Muscle diseases, such 
as the muscular dystrophies, in which the force transmission apparatus is compromised, 
have devastating effects on muscle function and quality of life.  Mechanical signals 
activate intracellular signaling to maintain function. ERK2 has been shown to be quickly 
and strongly upregulated following stretch, leading to cell proliferation.  Stretch has been 
shown to cause deformation of caveolae, invaginations of the plasma membrane that 
inhibit ERK signaling.  This leads to the hypothesis that stretch induced deformation of 
caveolae may initiate mechanotransduction by activating ERK2.  Reducing caveolin-3 
expression via siRNA knockdown eradicated the stretch-induced effect on ERK2 
activation, indicating that caveolin is required for the stretch response.  Stabilizing 
caveolae structure by temperature reduction or destabilizing caveolae by cholesterol 
depletion resulted in changes consistent with the hypothesis that proper caveolae 
structure plays an important role in inhibition of signaling molecules and that 







Skeletal muscle function is important to the human body for a variety of reasons.  
Day-to-day activities can be compromised by muscle atrophy secondary to sickness, 
obesity, or old age. There have been a variety of ways that previous work has attempted 
to illustrate the importance of stretch.  Among these is muscle growth resulting from 
post-natal passive stretch, atrophy due to old age or sickness, and illnesses such as 
muscular dystrophy.  For example, aging, a major cause of muscle loss, is associated with 
a decrease in overall muscle mass due to loss of muscle fibers, as well as, reduction in 
fiber size (Lexell, et al. 1988).   
Stretch-created mechanical signals are critical to the maintenance of muscle mass 
and function (Carson and Wei, 2000; Aronson, et al. 1997; Goldspink, Williams, and 
Simpson, 2002).  Mechanical signals lead to activation of signaling cascades, satellite cell 
proliferation, and cell differentiation, but the mechanism by which cells initiate 
mechanotransduction remains unclear (Carson and Wei, 2000; Tatsumi, et al. 2001; 
Powell, et al. 2002; Goldspink, Williams, and Simpson, 2002; Sadoshima and Izumo, 
1997).  Understanding how stretch mediates biochemical signaling is of great importance 
not only to fighting muscular dystrophy but also to help the elderly and sick maintain an 
independent and healthy life-style.  Caveolae have been shown to unfold during stretch 
and associate with a variety of inactive signaling molecules (Dulhunty & Franzini-
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Armstrong, 1975; Li, et al. 1996, Rybin et al. 1999, Galbiati, et al. 2000).  Caveolae may 
be a model for mechanotransduction in muscle cells. 
 
1.1.1 Postnatal Growth and Exercise  
  
Mechanical signals, such as post-natal growth and exercise, are critical to the 
normal development and maintenance of muscle (Carson and Wei, 2000; Aronson, et al. 
1997; Goldspink, Williams, and Simpson, 2002).  Passive stretch resulting from bone 
elongation is one of the critical determinants of postnatal muscle growth (Williams and 
Goldspink, 1976).  Stretch-induced mechanical stimulation of muscles has been linked to 
gene activation, increased protein synthesis, satellite cell proliferation, and differentiation 
(Powell, et al. 2002; Goldspink, Williams & Simpson, 2002; Tatsumi, et al. 2001; 
Sadoshima & Izumo, 1997).  Passive stretch also increases the presence of various 
growth factors, including insulin-like growth factor 1 (IGF-1) (Loughna, Mason and 
Bates, 1992).   
Exercise is largely emphasized these days as an important way to remain healthy 
and maintain muscle mass.  Exercise has been shown to increase protein synthesis and 
gene expression (Goldberg, 1968; Chen, et al. 2002).  It can also initiate activation or 
augmentation of other molecules such as growth factors.  During chronic stretch, IGF-1 is 
released (McKoy, et al. 1999) and stimulates protein synthesis and satellite cell 
proliferation and differentiation (Florini, et al. 1996). 
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1.1.2 Disruptions in mechanical signaling 
 
Reductions in mechanical stimuli, or disruption of the mechanotransduction 
machinery, leads to a corresponding loss of muscle function.  As people age, they tend to 
develop a more sedentary lifestyle, and this reduction of mechanical signaling leads to 
atrophy in skeletal muscles (Lexell, et al. 1988).  Disuse can lead to a decrease in the 
activation levels of signaling cascades such as ERK2 (Williamson, et al. 2003) and a 
decrease in muscle size and fiber size and number (Lexell, et al. 1988).   
Illness can also lead to a disruption of normal levels of muscle activation.  
Muscular dystrophies are a family of genetic diseases, which result in the disruption of 
the normal muscle growth and function (Galbiati, et al. 2000).  Duchenne muscular 
dystrophy (DMD) is the most common form of muscular dystrophy and is caused by a 
lack of dystrophin in the muscle cells (Hoffman, et al. 1987).  DMD is characterized by a 
loss of dystrophin and the presence of regenerating or immature muscle fibers (Galbiati, 
et al. 2000).  Mdx mice, the animal model for DMD, and DMD humans both show a 
compensatory increase in caveolin-3 expression in their muscles and increased density of 
caveolae (Vaghy, et al. 1998; Repetto, et al.1999).   
Limb-girdle muscular dystrophy 1C (LGMD-1C) is a mild form of muscular 
dystrophy that is caused by a mutation in caveolin-3, which causes caveolin-3 to be 
targeted for degradation (Galbiati, et al. 2000).  The mutant caveolin-3 is sequestered at 
the Golgi apparatus followed by proteasomal degradation and reduction by roughly 95% 
(Galbiati, et al. 2000; Minetti, et al. 2002).   Similar to LGMD-1C, targeted disruption of 
caveolin-3 leads to a decrease in caveolae at the sarcolemma, malformation of the T-
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tubule system, myopathic changes, and a loss of the dystrophin-glycoprotein complex 
from lipid rafts (Galbiati, et al. 2000).  This demonstrates that proper caveolae function is 




 Mechanotransduction is the transfer of an external mechanical signal at the cell 
surface into an internal signal.  Mechanical signaling can trigger events ranging from 
increased gene expression and protein synthesis to cell differentiation and proliferation 
(Goldberg, 1968; Chen, et al. 2002; Powell, et al. 2002; Goldspink, Williams & Simpson, 
2002; Tatsumi, et al. 2001; Sadoshima & Izumo, 1997).  Several mechanisms, including 
integrins (Maniotis, et al. 1997; Carson and Wei, 2000), membrane disruption (McNeil, 
et al. 1997; Lin, et al. 1997), and caveolae (Li, et al. 1996), have been implicated in 
mechanotransduction.    
 
1.2.1 Integrins    
 
 Integrins are a large family of transmembrane glycoprotein complexes mediating 
cell adhesion (Mayer, 2003).  Integrins have been shown to play a role in myoblast 
migration from the somite as well as in terminal differentiation into myotubes in 
developing muscle (Mayer, 2003).  Maniotis and colleagues (1997), using ECM coated 
beads to supply loads directly to integrins on skeletal muscle cells, found that 
deformation of the cell membrane resulted in nuclear deformation.  This suggests that 
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tension passed directly through the cytoskeleton to the nucleus may directly deform 
nuclear pores to alter gene transcription.  Integrins have also been shown to activate 
FAK, PI3-K, PKC, Ras, and Rho (Carson and Wei, 2000).  It is, however, difficult to 
separate the ligand-binding role of integrins from their mechanical role, and the 
mechanism by which integrins might mediate mechanotransduction remains unclear. 
 
1.2.2 Membrane Disruption 
  
 Skeletal muscles undergo one of the highest rates of membrane disruption found 
in animal muscles, which may lead to the release of cytosolic growth factors and calcium 
influx (McNeil and Steinhardt, 1997).  Following disruption, bFGF, a potent stimulator of 
cell proliferation, and aFGF are released in cell culture (McNeil, et al. 1989).  The 
movement of growth factors and calcium following stretch strongly suggest that 
membrane disruption plays at least a partial role in inducing signaling cascades in muscle 
cells (McNeil and Steinhardt, 1997).  Membrane disruption is a dramatic and potentially 
lethal event, and the membrane of mechanically active cells maintain a reserve of 
membrane material in caveolae to minimize the incidence of membrane disruption 
(Dulhunty & Franzini-Armstrong, 1975) 
 
1.2.3  Caveolae  
 
Caveolae are rounded, smooth invaginations of the plasma membrane 50-100nm 
in diameter (Galbiati, et al. 2000).  Caveolae are enriched in sphingolipids and 
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cholesterol, and their structure depends on the structural protein, caveolin (Rothberg, et 
al. 1992; Schlegel, et al. 1998).  Caveolae have been shown to unfold during stretch as a 
means by which the cells shield themselves from damage (Dulhunty & Franzini-
Armstrong, 1975).  Many signaling molecules, including MEK, Src, and PKCα, have 
also been shown to localize at caveolae (Li, et al, 1996; Rybin, et al. 1999).    
Caveolae are a subset of lipid rafts, microdomains within the plasma membrane 
that have a high concentration of sphingolipids and cholesterol (Li, et al. 1996; Rybin, et 
al. 1999; Veiga, et al. 2001).  Veiga and colleagues (2001) showed that lipid rafts are 
temperature-dependent.  At physiological temperatures, pure, synthetic sphingolipids 
exist in a gel phase having a melting temperature of ~42oC.  The addition of cholesterol 
allows for the sphingolipids to exist in a liquid-ordered state below their melting 
temperature, instead of in a gel state.  The physical phase of the raft domains is strongly 
temperature dependent near 37°C.  Of note, a shift to the gel phase occurs around 20-
30oC, depending on the molar fraction of cholesterol (Veiga, et al. 2001).  This 
phenomenon has long been used to block retrograde transport (Le and Nabi, 2003), and 
gelling the caveolae may prevent the mechanical deformation.     
  There are three known forms of the mammalian caveolin protein, caveolin-1, 2 
and 3, of which caveolin-3 is specific to striated muscle (Tang, et al. 1996).    Myoblast 
differentiation induces expression of the caveolin-3 gene (Galbiati, et al. 2000).  
Caveolin-3 is the main structural protein for caveolae in skeletal muscle (Galbiati, et al. 
2000).  Caveolin-3 is shown in myotubes to localize at the sarcolemma where it forms a 
complex with dystrophin (Galbiati, et al. 2000; Galbiati, et al. 1999).  Many signaling 
molecules co-localize with caveolin-3, including PKCα, Src, MEK, ERK, H-Ras, G-
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proteins, and e-Nos (Galbiati, et al. 2000).  Caveolin-3 binds to these molecules in their 
inactive form (Pol, et al. 1998).  This association may play an important role in 
mechanotransduction via caveolae. 
 The ERK cascade consists of three sequentially activated kinases: Raf-1 or B-Raf 
that phosphorylates MEK which phosphorylates ERK1/2.  In turn, Raf-1 is activated by 
Ras, and both can be activated by PKCα.  The most characterized results of the ERK 
MAPK cascade are regulation of cellular proliferation and control of the cell cycle 
(Sweatt, 2001).  ERK has been shown to be quickly and strongly upregulated following 
stretch (Sadoshima and Izumo, 1993; MacKenna, et al. 1998).  The association of the 
entire MAPK cascade with caveolae suggests that caveolae play an important role in 
transferring mechanical signaling from the cell surface to an ERK2 response. 
The associations of caveolae with these signaling molecules in their inactive state 
as well as the physical evidence that caveolae undergo deformation following stretch 
suggests that caveolae play an important role in transferring mechanical signal of stretch 




 The work outlined above suggests a mechanism by which mechanical 
deformations may lead to activation of biochemical signaling.  The importance of 
mechanical signaling to muscle’s normal maintenance and function has been extensively 
studied.  There is, however, no clear explanation for the transfer of the external 
mechanical signal to the resulting biochemical signal.  Caveolae associate with and 
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inhibit signaling molecules involved in muscle growth and hypertrophy.   Caveolae also 
are deformed following stretch, a change in conformation that may rearrange the 
carefully organized caveolin oligomeric structure.  This disruption may eliminate the 
inhibitory influence of the caveolin scaffolding domain on signaling molecules, resulting 
in the dis-inhibition of those signaling molecules.  We hypothesize that stretch-induced 
activation of ERK2 is mediated by caveolin-3.   
 
1.4 Experimental Design 
 
 Primary neonatal myoblasts were chosen because they have proven to be more 
myogenic in nature than established lines (Silberstein, et al. 1986).  A concern when 
using whole muscle is that being a whole muscle, there are other forces present which are 
capable of altering, for example, the response of a signaling cascade to an applied stretch.  
Using primary myoblasts allows for a very controlled environment and more believability 
in recorded results.   
Following the choice of primary myoblasts over whole muscle, a stretch protocol 
had to be chosen. Uniaxial stretch was chosen because skeletal muscle cells grow and 
fuse in a uniaxial direction both in culture and in whole muscle.  ERK2 was chosen as the 
illustrative signaling molecule due to the large amount of data previously gathered on it 
and the relative ease with which it can be measured.   For the actual protocol, three 
repeats of each experiment were performed to acquire enough data to be not only 
believable but also significantly measurable.  This helped also to keep sample number 
high even if membrane failure occurred before or during the stretch experiment. 
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The widely used protocol of cholesterol chelation via methyl-beta-cyclodextrin 
and the protocol for caveolae solidification via temperature control were used to alter 
caveolae deformability following stretch.  The cholesterol chelation experiments were 
designed based off preliminary work by another member of the lab.  A series of 
concentrations were used at first ranging from 0 to .75% cyclodextrin, and the final 
concentrations that were chosen were done so based off of cell viability following 
incubation in cyclodextrin. 
The temperature block experiments, which has been used in the past to alter 
caveolin shuttling to and from the cell surface, was used to attempt to make the caveolae 
more rigid, the opposite of the effect of cholesterol chelation on the caveolae.  However, 
these protocols are systemic in nature. 
 siRNA knockdown which specifically blocks caveolin-3 expression was chosen 
for its short preparation time and the specificity of the experiment.  siRNA was used to 
test the specific involvement of caveolin-3.  It was hoped that a complete picture of the 
role of the caveolae structure and caveolin-3 in ERK2 activation would provide support 
for the hypothesis.    
   There was some concern that transfecting the primary myotubes with siRNA 
might alter the cells’ natural responses to cyclic stretch.  A series of controls were 
selected to not only give a visual account of what was occurring in the transfected cells 
(non-silencing and immunostaining transfections), but also to show numerically any 
differences between the non-transfected and transfected populations (fusion index, 
myotube diameter, and myosin content.) 
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CHAPTER 2 
METHODS AND MATERIALS 
 
2.1 Isolation and Growth of Neonatal Mouse Myoblasts 
 
2.1.1 Isolation of Neonatal Mouse Myoblasts 
 
 Myoblasts were isolated by enzymatic digestion of hind limb musculature (Rando 
& Blau, 1994).  Two-five day old CFW mouse pups (Swiss-Webster, Charles River Labs) 
were sacrificed by carbon dioxide asphyxiation, decapitated, and immersed in 70% 
ethanol.  Hind limbs were removed from 3-4 pups at a time and kept on ice.  The muscle 
tissue was dissected from the bone and skin, and minced with razor blades in 0.5 mL of 
dissociation solution (PBS containing 10 mM CaCl2, 1.5 U/ml collagenase, 2.4 U/ml 
dispase).  The minced muscle was removed to a 15 mL centrifuge tube, and the dish was 
washed with another 0.5 mL of dissociation solution.  The tissue slurry was incubated for 
30 min at 37oC.  The slurry was filtered through a 100 µm mesh strainer into a 50 mL 
centrifuge tube, the strainer was rinsed with an additional 5 mL of growth media (Ham’s 
F10 nutrient solution (F10) supplemented with 20% FBS, 2.5 ng/ml bFGF, 100 IU/ml 
penicillin and 100 µg/ml streptomycin), and the cells pelleted for 5 min at 350x gravity.  
The cell pellet was resuspended in 12 ml of F10. Cells were plated on collagen-coated 
dishes and identified as passage 0.  Myoblasts were purified from fibroblasts and 
adipocytes through 10-12 successive passages by selective trypsinization and differential 
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adhesion (Rando & Blau, 1994).  In the following experiments, no passage older than 
P19 was used due to observed changes in morphology at that time.  
 
2.1.2 Myogenic Testing 
 
 Myogenicity was evaluated by desmin, which is only expressed in myogenic 
cells.  Cells were plated on a 6-well dish and allowed to proliferate.  The cells were 
rinsed twice with phosphate buffered saline (PBS) and fixed for 5 min in 4% 
paraformaldehyde in PBS.  The wells were then rinsed with PBS and permeabilized for 5 
min in 1% Triton X-100 in PBS.  The wells were rinsed once more in PBS and blocked in 
5% BSA in PBS for 1 hour.  Cells were incubated with 1:200 anti-desmin (Vector) for 1 
hour.  All wells were rinsed 3 times with PBS for 15 min, followed by alkaline 
phosphatase conjugated anti-mouse secondary antibody (SCBT, 1:100).  The wells were 
rinsed 3 more times with PBS for 15 min and then rinsed with AP buffer (water with 124 
mM Tris, 128 mM NaCl, and 6 mM MgCl2 ) for 5 min.  The cells were colored with a 
nitro blue tetrazolium /bromochloroindolyl phosphate solution (NBT/BCIP) until color 
developed.  The cells were rinsed with water and covered with glycerol.   
 Cells were imaged using phase contrast and conventional illumination.  For each 
picture the cells were counted and the percentage of desmin-positive cells calculated.  





2.2 TEM Pictures 
 
C57 primary cells or mdx cells were seeded onto matrigel-coated cassettes as previously 
described.  Following myoblast fusion into myotubes, cells were rinsed and fixed for 1 
hour in 1.6% paraformaldehyde and 3% glutaraldehyde in 100 mM sodium cacodylate 
buffer (pH 7.3) at 4oC.  They were then washed in 3.5% sucrose in cacodylate buffer and 
post-fixed in 1% Palade’s OsO4 for 1 hour.  Membranes were stained en bloc with uranyl 
acetate, dehydrated and fixed in epoxy.  Sections were cut at 90 nm and viewed by 
transmission electron microscopy and photographed. 
 
 2.3 Cell Maintenance and Membrane Seeding 
 
 Cells were passed every other day.  Cells to be passed were washed twice with 
PBS and incubated for two minutes with 1.5 mL trypsin.  Following trypsin incubation 
13.5 ml of growth media was added, and the cells collected in a 50 mL tube.  An aliquot 
of the cells was collected for determination of cell number, and the tube was centrifuged 
at 100x gravity for 10 minutes.  After centrifugation the cell pellet was resuspended in 
F10 media. Cells were seeded at 5-10x103 cm-2 on collagen coated culture dishes or 104 






2.4 Stretch Experiment Prep. 
 
 
 2.4.1 Stretch Apparatus 
 
 The cassettes consist of a silastic sheet mounted in clamshell shaped clamps to 
form wells (Figure 2.1).  After the cassette was built, a u-clamp was attached to the top of 
the cassette and the cassette stretched to 1.9 inches.  The cassettes were autoclaved and 
coated with 0.2 mg/ml growth factor reduced matrigel (Becton Dickinson).  The matrigel 


















2.4.2 CFW Growth on Membranes 
  
Cells were allowed to proliferate in growth media up to two days after passage.  
At roughly 70% confluence, the membranes were stretched to 2.2 inches (25% of seeding 
length) (Burkholder 2003) to promote unidirectional fusion of the myotubes as seen in 
Figure 2.3.  Stretches were performed using a custom, stepper motor driven device 
controlled by Labview software (Figure 2.2).  Following the stretch, media was changed 
to differentiation media (Dulbecco’s Modified Eagles Media (DMEM) plus 2% horse 
serum and antibiotics) to promote differentiation of the cells.  Cells were allowed to 






Figure 2.2 – Cassette Stretcher 
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Figure 2.3 – Image of aligned and fused myotubes grow
 
 
2.5 Stretch Experiments 
 
2.5.1 Stretch Protocol 
 
 Cultures were pre-incubated in CMG (PBS with 0.0
and 0.07% glucose) prior to stretch. Membranes were stret
minutes at +/- 15% rest length.  Following stretch the mem
cold PBS twice and harvested in 100-150 µL of non-denatu
with 1% Triton-X 100, 0.05 M tris, 0.25 M NaCl, 0.025 M
inhibitors, and 4µg/ml NaVO3) was added.  Samples were 
ice.  The lysates were centrifuged for 5 minutes at 6000x g
debris.  Protein concentration was measured using a Bicinc
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2.5.2 Modifications of Caveolae  
 
To disrupt the caveolae structure, some cultures were incubated for an hour in 
CMG plus 0.1% or 0.5% methyl-beta-cyclodextrin (MβCD) to chelate cholesterol and 
disrupt caveolae structure.  To increase the rigidity of caveolae, some cultures were held 
at room temperature for the final 15 minutes of the pre-incubation.  Stretch of those 
cultures was also carried out at room temperature.  Additional membranes remained 
static, at either room temperature or 37°C to serve as controls.  Following temperature 
control or cholesterol chelation, cultures were treated with the addition of FGF to assess 
the viability of the cell population and test for non-specific disruption or saturation of 
ERK2 signaling.  The time course included a 0, 5, 15, 25, and 40 minute time point 
encompassing both before and after the time course of a normal stretch experiment  
 
2.6 Caveolin-3 Knockdown  
 
2.6.1 siRNA Protocol 
 
 Three validated siRNA’s previously tested for specific caveolin-3 mRNA 
knockdown were evaluated for knockdown efficacy.  RNA oligos were transfected into 
differentiated myotubes using a commercially available cationic lipid reagent 
(Oligofectamine, Invitrogen), according to the manufacturer's instructions.  Briefly, 
siRNA was diluted to 18.3 µg/ml in serum free DMEM, and oligofectamine was diluted 
1:5 in serum free DMEM.  These mixtures were centrifuged briefly and incubated at 
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room temperature for 5 minutes.  The diluted lipid reagent was then added 2:9 to the 
siRNA mixture and incubated a further 15 minutes at room temperature.  The cells were 
rinsed once with serum free DMEM, and bathed in serum free DMEM.  Lipid:RNA 
complexes were applied to the cells, and an equivalent amount of lipid reagent was 
applied to control cultures.  Cultures were incubated with the transfection mixture for 6 
hours, rocked every 2 hours, and then supplemented with  
125 µL per well of DMEM plus 6% Horse serum.  Parallel cultures were transfected with  
fluorescein-tagged non-silencing RNA oligomers (Qiagen) and imaged under 
epifluorescent illumination to determine transfection efficiency.  Cultures were 
maintained for an additional 2 days, harvested in detergent buffer, and assayed for 
caveolin-3 expression by Western blot.  Pilot experiments indicated that that the three 
oligomers resulted in equivalent knockdown (91.2 ± 8.9%, 91 ± 5%, and 86.5 ± 6.6%), 
and the "cav3-1" oligomer (5'-GGACAUUGUGAAGGUAGAUtt-3') was used for all 
further experiments.   
 
2.6.2 Time Course of knockdown   
 
 Transfected cultures were harvested at 6, 12, and 24 hours following transfection 






2.7 Bicinchoninic Acid Protein Assay 
 
 A set of eight standards was made using 160 µL of tris, sodium chloride, and 
EDTA (TNE) in the first well and 100 µL in the following seven wells.  Forty microliters 
of 10 mg/ml bovine serum albumin (BSA) was added to the first well and the following 
six wells were consecutively diluted down by adding 100 µL from the previous well.  
Standards and samples were loaded as duplicates into a spectrophotometer plate at a 
volume of 10 µL per well.  Using a kit purchased from Pierce, a dying solution of 10 ml 
of protein assay reagent A (sodium carbonate, sodium bicarbonate, BCA detection 
reagent, and sodium tartrate in 0.1 N sodium hydroxide) per 200 µL of protein assay 
reagent B (4% cupric sulfate) was made, and 200 µL of the solution was added to each 
well.  The plate was incubated at 37oC for thirty minutes.  The plate was read at  
562 nm in the spectrophotometer using KCJr software. 
 
2.8 Protein Analysis 
 
 All protein samples were separated by SDS-PAGE using 7.5, 9, 10, or 12% 
acrylamide gels.    For Western blotting, proteins were transferred for one hour at 1.5 mA 
per cm2 onto a nitrocellulose membrane using a semi-dry transfer system.  Following 
transfer, the membranes were blocked with 1% BSA, hybridized with primary antibodies 
against ERK2 (Transduction Laboratories), phosphorylated ERK (Cell Signaling), or 
caveolin-3 (BD). Membranes were incubated for one hour in a blocking solution of 2% 
BSA in TTBS (water with NaCl, tris-base, tris-HCL, and Tween 20) at room temperature 
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or overnight at 4oC followed incubation in a primary antibody, three 15 minute rinses in 
TTBS, incubation with an HRP conjugated secondary antibody (1:20,000), and three 
more 15-minute rinses in TTBS.  Membranes were incubated with ECL (Amersham) for 
five minutes and exposed to Kodak film.  Membranes probed for phospho-specific 
antibodies were subsequently stripped and re-probed with non-phospho specific 
antibodies.  Films were digitized on a scanner and quantitated using Matlab.  ERK2 
phosphorylation was determined by normalizing phospho-specific integrated optical 
density (IOD) to the non-phospho specific IOD.  Each sample from a particular film was 
then normalized to the mean IOD ratio for the control samples from that film. 
For assay of myosin content, gels were fixed (50% MeOH, 10% HOAc), and 
stained with 0.025% Coomassie blue.  Gels were extensively destained, scanned, and 
relative myosin content determined by IOD. 
 
2.9 Cell morphology 
 
Fusion index and myotube diameter were measured to evaluate any effect on 
myotube viability or morphology.  Briefly, fusion index was taken by fixing the 
membranes in 0.4% paraformaldehyde, rinsing in PBS, adding a couple of drops of 
hematoxylin, acid alcohol, and saturated lithium carbonate, and rinsing again in water.  





2.10 Immunostaining of Membranes 
 
 Caveolin-3 expression following knockdown was also evaluated by 
immunocytochemistry.  Membranes were rinsed with PBS, and fixed with 50% methanol 
in PBS for 5 minutes.  The membranes were rinsed twice and blocked in 5% BSA in PBS 
for one hour.  Cultures were incubated with caveolin-3 antibody (1:100 Santa Cruz) for 
30 minutes, rinsed, and incubated with fluorescein-tagged secondary antibody (1:100).  
The membranes were rinsed twice more in PBS for 5 minutes each and covered in 
glycerol.  Pictures were taken at 20X magnification under epifluorescent illumination. 
 
2.11 Statistical Analysis   
 
Results were analyzed by one- or two-way ANOVA using Statview 5.01 (SAS).  Fisher's 
PLSD correction was applied to post-hoc T-tests to evaluate specific differences between 
treatments. The significance threshold was set to p<0.05, and all data are reported as 














3.1 Myogenic Testing 
 
Desmin immunostaining was used to identify myogenic cells (Figure 3.1).  Of the 
1398 cells counted in 16 fields, 99 ± 1% were desmin positive (n = 16 fields). 
   
A B 
50 µm 50 µm 
Figure 3.1 – Desmin stained myoblasts in conventional (A) and phase-contrast (B) illumination. 
 
3.2 Fusion Index 
  
Fusion index was determined from 6 visual fields randomly selected from culture 
wells.  Of the 1197 nuclei observed, 90.6% were in multinucleated myotubes.  This 
compares well with the expected range of 70-90% (Rando & Blau, 1994).  Individual 






3.3 Caveolae Morphology 
 
 Caveolae morphology in the fused myotubes used in these experiments was 
evaluated by TEM.  Images of stretched myotubes revealed what appeared to be caveolae 
with a flattened-out morphology, which were not seen in unstretched myotubes  
(Figure 3.2).  TEM images were not quantified in any way and were only used as 
illustrative evidence. 
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significant difference in ERK2 activation of p<0.01 (†).  Varying the amplitudes showed 
a significant increase in ERK2 activation of p<0.01 (*) for the 15%, 20% and 30% 
amplitudes at 20%/second. 
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Figure 3. 4 - ERK2 phosphorylation in response to stretch following 1hr pre-incubation with MβCD 
(*=p<0.01 for pre-incubation media, Mean±S.D.). (parenthetical numbers provide sample number)  
 
 
3.5.2 FGF Experiments with MβCD 
 
 A possibility with the MβCD pre-incubation was the saturation of the ERK2 
signaling response following chelation of cholesterol.  To determine whether this was the 
case, 0.1% MβCD-treated cells were treated with FGF and harvested at 0, 5, 15, 25, and 
40 minutes time points.  Static cells treated with 0.1% MβCD responded to bFGF 
treatment similar to untreated controls (Figure 3.5), indicating that CD treatment does not 
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3.6.1 Non-silencing Membrane Transfections 
 
 
 Membranes were transfected with fluorescein-tagged, non-silencing RNA 
oligomers to evaluate transfection efficiency.  Control wells subjected to oligofectamine 
without the siRNA oligo showed no fluorescence, while 86% of transfected myotubes 







  250 µm
Figure 3. 6 – Transfection with fluorescein-tagged RNA oligos (C) revealed efficient uptake of RNA.  




3.6.2 Evaluation of Cav3 siRNA Knockdown   
 
 
 Three validated caveolin-3 siRNA oligomers were evaluated for their relative 
ability to knockdown caveolin-3 (Figure 3.7).  Transfection resulted in significant 
knockdown compared to the non-transfected controls (p<0.001).  Knockdown recorded 
was 91.0 ± 9.0 % for cav3-1, 91.0 ± 5.0% for cav3-2, and 87.0 ± 7.0% for cav3-3. 
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 Membranes were immunostained with anti-cav3 to assess the presence of 
caveolae at the membrane surface.  The intensity of labeling in transfected cultures was 
dramatically reduced relative to untreated controls (Figure 3.8).  Fluorescence in 
untreated cultures was strongly associated with the cell membrane, but what fluorescence 
was apparent in transfected cultures was uniformly distributed within the cytoplasm. 
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Myotube diameter was measured to determine whether transfection altered fusion 
rate or cell viability (n = 16).  On average, non-transfected myotubes had a diameter of 
20.7 ± 6.6 µm, and transfected myotubes had a diameter of 21.1 ± 2.6 µm.  No significant 
changes were seen in any of the samples measured.   
 




Myotubes grown on stretch cassettes and transfected with Cav3 siRNA displayed 
slightly less effective caveolin-3 knockdown of just 50 ± 26% at the protein level in the 
unstretched cultures and 41 ± 25% in those subjected to knockdown and stretch (p<0.001, 
Figure 3.11). 
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Figure 3. 11– Knockdown of caveolin-3 following transfection with cav3-1 in stretched and unstretched 




Despite the less effective knockdown, phosphorylation of ERK2 was significantly 
different in transfected vs. non-transfected samples (p <0.05, Figure 3.12).  There was no 
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significantly reduced the caveolin-3  recovered from cultures  (Figure 3.13).  Caveolin-3 
dropped to 11 ± 9% in the 22oC non-transfected, unstretched controls and 20  ± 11% in 
the 22oC non-transfected, stretched cultures.  Differences between control and stretch 
samples were not resolvable.  
Myosin content dropped from 90 ± 40% in the 37oC samples to 60 ± 30% in the 
22oC samples (p<0.01), suggesting that the temperature dependent differences likely 
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Figure 3. 15 - FGF stimulated ERK2 phosphorylation at room temperature (22oC), (parenthetical numbers 



















We hypothesized that stretch-induced activation of ERK2 is mediated by 
caveolin-3.  From previous data, we know that caveolae unfold during stretch and that 
caveolin-3 binds to and inhibits several signaling molecules involved in the stretch 
response (Dulhunti and Franzini-Armstrong, 1975; Galbiati, et al. 2000; Pol, et al. 1998).  
We suggest that following stretch, caveolin-3, and thus the signaling molecules it is 
bound to, is pushed off the caveolae structure causing a conformational change in how it 
is bound to the signaling molecules.  This in turn allows those molecules, such as ERK2, 
to become activated and carry out their downstream tasks.   
Our data shows that caveolin-3 does play an important role in the stretch-induced 
activation of ERK2.  Knockdown of the caveolin-3 protein by 50% results in the loss of 
the stretch-induced ERK2 activation.  Morphological data and myosin content indicate 
that transfection does not fundamentally alter the cells, supporting the idea that it is the 
loss of caveolin-3 protein that causes the loss of ERK2 activation.   
As explained above, caveolin-3  inhibits ERK2 to maintain a low resting activity 
(Pol, et al. 1998).  The loss of the stretch response seen after knockdown may explain 
why muscular dystrophies have the phenotypes they do.  From previous research it is 
known that LGMD-1C is characterized by a loss of caveolin in the skeletal muscle cells, 
similar to using siRNA to knock down caveolin-3 expression (Galbiati, et al. 2000; 
Minetti, et al. 2002).  Muscles of LGMD-1C patients, as a result, undergo myopathic 
changes and other alterations in the cells’ signal transduction machinery such as the t-
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tubule system (Galbiati, et al. 2000).  In the siRNA protocol, transfected cells show an 
increase in basal levels of ERK2 activation but a loss of the ERK2 stretch-response.  
Removing caveolin-3 from the cells may distort or completely remove caveolae present 
at the cell surface.  This, in turn, may allow for the signaling molecules normally 
associated with and inhibited by caveolin-3 to become chronically activated.  If 
deformation of the caveolae structure is necessary for normal activation and deactivation 
of these signaling cascades, this could explain why patients with LGMD-1C show signs 
of continual muscle turnover and alterations in the cells’ mechanotransduction 
machinery.  Disruption of the caveolae structure would lead to chronic activation of the 
signaling cascades, as well as, a loss in the cells’ ability to control their activation via 
caveolae deformation.  This idea can also be taken and used to explain other disease 
phenotypes due to chronic activation of any of the other signaling molecules and 
cascades associated with caveolae. 
Other less specific protocols were also used to attempt to connect the importance 
of normal caveolae deformation following stretch and signaling cascade 
activation/deactivation.  Destabilization of the caveolae structure was attempted via 
cholesterol chelation using methyl-beta-cyclodextrin.  Cholesterol is an important 
member of the caveolae structure.  It interacts with sphingolipids to create the liquid-
ordered state present in caveolae (Veiga, et al. 2001).  The physical effect of cholesterol 
depletion is dependent on the specific distribution of cholesterol in the cell.  Pre-
incubation with 0.1% MβCD resulted in increased ERK2 activation in both static and 
stretched cultures. Pre-incubation with 0.5% MβCD showed no difference with ERK2 
activation in untreated cells that was inconsistent with the 0.1% MβCD samples’ data.  In 
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the same way that knockdown of caveolin-3 with siRNA led to an increase in the basal 
levels of ERK2 activation, treatment with MβCD may cause the overall increase in ERK2 
activation.  Chelation of cholesterol may be enough to destabilize the caveolae structure, 
driving off some of the caveolin-3, and resulting in an increase in the basal level of ERK2 
activation.  It is not able, however, to destabilize the caveolae structure enough to remove 
the stretch response.  Thus, the 0.1% MβCD data is consistent with destabilization of 
caveolae in the context of the proposed model offering additional data that confirms that 
normal deformation of caveolae and the resulting alterations in caveolin-3 are necessary 
for control of the signaling molecules associated with caveolin-3.  
It should be noted that using MβCD to chelate cholesterol specifically out of 
caveolae, while a common protocol, is highly sensitive to application (Smart & 
Anderson, 2002). Without assaying the morphology of caveolae by EM, or the 
association of caveolin with lipid rafts by gradient fractionation, it is not possible to be 
certain exactly what the cyclodextrin treatment accomplished. Cells did respond as 
expected to stimulation with bFGF, though, so it is not likely that the inconsistencies in 
the data resulted from massive cell death or extensive disruption of intracellular signaling 
for the 0.1% MβCD pre-incubation. 
Pre-incubation at room temperature was used to minimize the deformation of 
caveolae by stretch by inducing a liquid to gel phase transition in the caveolae, increasing 
their rigidity and resistance to deformation.  An increase in basal levels of ERK2 
activation was seen in the 22oC samples with a loss of the stretch-response in both non-
transfected and transfected samples.  Transfected samples were also significantly 
different than the non-transfected ones at 22oC.  This suggests that the caveolae structural 
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integrity matters for proper inhibition of the ERK2 cascade, and that removal of caveolin-
3 will accomplish the same thing as temperature control, increasing the basal level of 
ERK2 activation and removing the stretch-dependent response. 
It was thought that lowering the temperature of the cells and gelling the 
sphingolipids in the caveolae would minimize caveolae deformation and block ERK2 
activation by stabilizing the association between membrane-bound caveolin and ERK2.  
The overall increase in ERK2 activation in the cold samples, however, suggests that the 
unique liquid-ordered properties of these rafts are key in the inhibition of the signaling 
cascades.  This could be due to disruption of the striated caveolin coat that covers the 
entire caveolae surface.  Gelling the caveolae may result in local deformation of how 
caveolin binds to the other structural elements of caveolae, to itself, and even to the 
signaling molecules associated with it.  Deformation of caveolin would then alter the way 
it binds and inhibits signaling molecule activation allowing for the signaling molecules to 
bind to other factors and become activated.  This suggests that disruption of the natural 
ordered structure of caveolae is a viable means by which signaling molecules can become 
exposed in a way that allows for their activation to occur.   
Pre-incubation at 22oC had the unexpected result of significantly lowering the 
amount of caveolin-3 measured in the samples.  Myosin levels were compared in these 
samples, and it was seen that there was a significant drop in myosin in the 22oC samples.  
This may mean that pre-incubation is resulting in at least the partial death of myotubes 
leading to the lower levels of caveolin-3 and myosin measured in the temperature control 
samples.  However, the myotubes present still responded as expected to FGF stimulation. 
This may indicate that even if there is some cell death occurring, it is not enough to alter 
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the cells still present and their natural stretch-induced responses.  This may also indicate 
only that ERK2 activation is not being saturated in these particular samples even if the 
natural stretch-response has been altered by the protocol. 
Further work needs to be done to verify the data shown in this paper.  Following 
up on the siRNA work, other cascades either associated with ERK2 and caveolae, such as 
nNOS, PLA2, and a variety of G-proteins, or associated with the general hypertrophic 
response could be studied to attain a better feel for what was occurring in the knockdown 
cells. 
To improve visually our understanding behind what was occurring in these cells, 
both transfected and non-transfected, more TEM pictures could be taken so as to be able 
to actually quantify the caveolae present.  Staining in the TEM pictures for caveolin-3 
would also be helpful in determining whether or not the structures seen were indeed 
caveolae.  The immunostained samples could also be dually stained with a phosphoERK 
antibody to visualize whether what is believed to be caveolin-3 truly is the molecule 
associated with ERK2.  To study whether the changes in ERK2 activation were only due 
to increased disruption of the membranes, a reason perhaps for the increase in caveolae in 
DMD patients’ cells, Fdx assays could also be run. 
 
4.1 Clinical Importance 
 
 As suggested in the introduction, caveolae may open when muscles are stretched.  
In addition to its role in controlling signaling cascades, caveolae may act as sources of 
excess membrane during stretch protected cells from membrane disruption or injury. In 
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combination with the association of caveolin-3 with multiple inactive signaling 
molecules, this implies that caveolae may play an important role in the maintenance of 
skeletal muscle.  If caveolae are truly present to act as a means by which signaling 
cascades are activated during stretch, then the associated muscle growth with passive 
bone growth might be a result of constant, though low, activation of signaling cascades 
due to caveolae deformation and alterations in the caveolin-3 binding to the signaling 
molecules. 
 One of the most common means to treat high blood cholesterol is to prescribe 
some form of statin, which block the synthesis of cholesterol, leading to reductions of 
circulating cholesterol. Among the major side effects of statins is muscle weakness and 
pain, and it may be that reducing the body’s cholesterol levels mimics the MβCD 
chelation of cholesterol out of the caveolae (Moghadasian, 2002).  The disruption of the 
caveolae structure and the potential loss of caveolae due to the taking of statins may lead 
to chronic increases in basal activation of ERK2 and, in turn, muscle loss causing pain 
and weakness. 
 LGMD-1C, which results in the extreme loss of caveolin-3 from the cell surface, 
may in turn be an extreme example of the effects of disrupting caveolae structure and 
caveolin-3 function (Galbiati, et al. 2000; Minetti, et al. 2002).  The resulting phenotype 
in LGMD-1C patients may be due to the chronic activation of ERK2 and all its 
downstream targets (Woodman, et al. 2002), as well as, the loss of the cells’ ability to 
mediate ERK2 activation via stretch. 
Showing that caveolin-3 is important for the ERK2 stretch-induced response is a 
step in uncovering how caveolin-3 mediates mechanotransduction in skeletal muscle 
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cells.  It may help explain some of the phenotypic effects of muscular dystrophies, and 
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